663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis

Bibliographic Details
Main Authors: Faisal Khan, Shameer Khader, Youyi Zhang, Daniel Jackson, Kirsty Rhodes, Imran Khan Anwer Neelufer, Sreenath Nampally, Andrzej Prokop, Emmette Hutchison, Jiabu Ye, Feng Liu, Antony Sabin, James Weatherall, Cristina Duran, Renee Iacona, Pralay Mukhopadhyay
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1818608994203205632
author Faisal Khan
Shameer Khader
Youyi Zhang
Daniel Jackson
Kirsty Rhodes
Imran Khan Anwer Neelufer
Sreenath Nampally
Andrzej Prokop
Emmette Hutchison
Jiabu Ye
Feng Liu
Antony Sabin
James Weatherall
Cristina Duran
Renee Iacona
Pralay Mukhopadhyay
author_facet Faisal Khan
Shameer Khader
Youyi Zhang
Daniel Jackson
Kirsty Rhodes
Imran Khan Anwer Neelufer
Sreenath Nampally
Andrzej Prokop
Emmette Hutchison
Jiabu Ye
Feng Liu
Antony Sabin
James Weatherall
Cristina Duran
Renee Iacona
Pralay Mukhopadhyay
author_sort Faisal Khan
collection DOAJ
first_indexed 2024-12-16T14:51:29Z
format Article
id doaj.art-1db2c31bb5ed40ba9d561bb18d4f0cba
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-16T14:51:29Z
publishDate 2020-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-1db2c31bb5ed40ba9d561bb18d4f0cba2022-12-21T22:27:34ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0663663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysisFaisal Khan0Shameer Khader1Youyi Zhang2Daniel Jackson3Kirsty Rhodes4Imran Khan Anwer Neelufer5Sreenath Nampally6Andrzej Prokop7Emmette Hutchison8Jiabu Ye9Feng Liu10Antony Sabin11James Weatherall12Cristina Duran13Renee Iacona14Pralay Mukhopadhyay151AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA2AstraZeneca Pharma Poland, Warsaw, MD, Poland1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA
spellingShingle Faisal Khan
Shameer Khader
Youyi Zhang
Daniel Jackson
Kirsty Rhodes
Imran Khan Anwer Neelufer
Sreenath Nampally
Andrzej Prokop
Emmette Hutchison
Jiabu Ye
Feng Liu
Antony Sabin
James Weatherall
Cristina Duran
Renee Iacona
Pralay Mukhopadhyay
663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
Journal for ImmunoTherapy of Cancer
title 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
title_full 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
title_fullStr 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
title_full_unstemmed 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
title_short 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
title_sort 663 correlation between early endpoints and overall survival in non small cell lung cancer a trial level meta analysis
work_keys_str_mv AT faisalkhan 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT shameerkhader 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT youyizhang 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT danieljackson 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT kirstyrhodes 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT imrankhananwerneelufer 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT sreenathnampally 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT andrzejprokop 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT emmettehutchison 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT jiabuye 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT fengliu 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT antonysabin 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT jamesweatherall 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT cristinaduran 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT reneeiacona 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis
AT pralaymukhopadhyay 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis